TH864C3 - Drug addiction treatment regimen - Google Patents
Drug addiction treatment regimenInfo
- Publication number
- TH864C3 TH864C3 TH203001023U TH0203001023U TH864C3 TH 864 C3 TH864 C3 TH 864C3 TH 203001023 U TH203001023 U TH 203001023U TH 0203001023 U TH0203001023 U TH 0203001023U TH 864 C3 TH864 C3 TH 864C3
- Authority
- TH
- Thailand
- Prior art keywords
- drug addiction
- treatment regimen
- addiction treatment
- vitamin
- hydrochloride
- Prior art date
Links
- 206010013663 drug dependence Diseases 0.000 title claims abstract 3
- 208000011117 substance-related disease Diseases 0.000 title claims abstract 3
- 238000011269 treatment regimen Methods 0.000 title 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims abstract 4
- 229960003495 thiamine Drugs 0.000 claims abstract 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract 2
- 229930003451 Vitamin B1 Natural products 0.000 claims abstract 2
- 229930003268 Vitamin C Natural products 0.000 claims abstract 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims abstract 2
- 235000010374 vitamin B1 Nutrition 0.000 claims abstract 2
- 239000011691 vitamin B1 Substances 0.000 claims abstract 2
- 235000019158 vitamin B6 Nutrition 0.000 claims abstract 2
- 239000011726 vitamin B6 Substances 0.000 claims abstract 2
- 235000019154 vitamin C Nutrition 0.000 claims abstract 2
- 239000011718 vitamin C Substances 0.000 claims abstract 2
- 229940011671 vitamin b6 Drugs 0.000 claims abstract 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 claims 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims 1
- 235000019157 thiamine Nutrition 0.000 claims 1
- 239000011721 thiamine Substances 0.000 claims 1
- 229930003779 Vitamin B12 Natural products 0.000 abstract 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 abstract 1
- 235000019163 vitamin B12 Nutrition 0.000 abstract 1
- 239000011715 vitamin B12 Substances 0.000 abstract 1
Abstract
สูตรยารักษาโรคที่เกิดจากการติดยาเสพติดที่ประกอบขึ้นด้วย เฟนแคมฟามิน ไฮโดร คลอไรด์ วิตามิน บี 1 วิตามิน บี 6 วิตามิน บี 12 และวิตามิน ซี สิทธิบัตรยา Drug addiction treatment formulation containing fencamphamin hydrochloride, vitamin B1, vitamin B6, vitamin B12 and vitamin C.
Claims (1)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH864C3 true TH864C3 (en) | 2002-11-06 |
| TH864A3 TH864A3 (en) | 2002-11-06 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR038527A1 (en) | DOSAGE FORM CONTAINING A PDE 4 INHIBITOR AS ACTIVE INGREDIENT | |
| NO20054244D0 (en) | Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient | |
| MXPA04005877A (en) | Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailability. | |
| DK1498411T3 (en) | Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient | |
| IS7735A (en) | Benzodiazepine derivatives and pharmaceutical compositions containing them. | |
| NO20022334D0 (en) | New composition and application | |
| AU2003303633A8 (en) | Fast dissolving films for oral administration of drugs | |
| DK1557415T3 (en) | Heterocyclic compounds and antitumor drugs containing the same as the active ingredient | |
| WO2004032909A3 (en) | Stabilized pharmaceutical composition containing basic excipients | |
| CY1110664T1 (en) | INTENSIVE COMPOSITION | |
| IL159217A0 (en) | An oral pharmaceutical formulation comprising a basic pharmaceutically active ingredient having ph-dependent solubility, a process for the manufacture thereof and use thereof in medicine | |
| WO2004032866A3 (en) | Therapeutic formulations | |
| CO5540294A2 (en) | A COMBINATION OF A RAPAMYCIN DERIVATIVE AND A SELECTED RENTING AGENT OF CYCLPHOSPHAMIDE AND CARMUSTINE AND COMPOSITIONS CONTAINING THEM | |
| DE60102590T2 (en) | PHARMACEUTICAL FORMS FOR THE TREATMENT OF ORAL MYCOSES | |
| TH864A3 (en) | Drug addiction treatment regimen | |
| TH864C3 (en) | Drug addiction treatment regimen | |
| EA200701409A1 (en) | NEW COMPOSITION | |
| NO20043314L (en) | Sedative non-benzodiazepine formulations | |
| MXPA02011883A (en) | A combination kit used in the treatment of malaria. | |
| EG23366A (en) | Oral film containing chlorhexidine hydrochloride and benzydamine hydrochloride for treatment of gingivitis, peridontitis and oral infections. | |
| TH77592A (en) | Dosage form containing PDE4 inhibitor as the active ingredient. | |
| RU2006145711A (en) | METHOD FOR PREVENTION OF ACUTE RESPIRATORY INFECTIONS IN CHILDREN REPEATEDLY REPEATING THEM | |
| TNSN05334A1 (en) | A combination kit in the treatment of malaria | |
| RU2003130672A (en) | MEANS FOR TREATMENT AND PREVENTION OF ATHEROSCLEROSIS | |
| TNSN02095A1 (en) | A combination kit used in the treatment of malaria |